Mendelspod
Subscribe
Sign in
Home
Archive
About
Latest
Top
Discussions
Elias Sayour on the Cancer Vaccine Breakthrough
After being pursued for more than 150 years, cancer vaccines may finally be having their moment.
7 hrs ago
•
Theral Timpson
1
1
28:00
What Single Cell Sequencing Revealed About Pulmonary Fibrosis with Nick Banovich, TGen
Co-produced with GenomeWeb
Sep 8
•
Theral Timpson
4
1
37:24
The Quest to Measure Protein Function with Polly Fordyce, Stanford
Stanford physicist and bioengineer Polly Fordyce has a big vision.
Sep 3
•
Theral Timpson
1
1
31:36
Doubling Down on Long Reads: New CEO of PacBio, Mark Van Oene
Mark Van Oene has just taken over as CEO of Pacific Biosciences, and Mendelspod is his first interview in the new job.
Sep 1
•
Theral Timpson
3
1
31:04
August 2026
Serge Saxonov on What’s Next for 10x Genomics
10x Genomics has been remarkably good at figuring out where biology is going next.
Aug 27
•
Theral Timpson
4
2
49:22
“You Cannot Discover What You Cannot Make”: Lee Cronin on Programming Chemistry
Those of us in biology tend to think that chemistry is rather straight forward.
Aug 20
•
Theral Timpson
2
39:34
All of Us Comes of Age. And So Does Its Funding: Josh Denny on the Next Phase of Precision Medicine
There are very few genomics projects with the level of ambition of the NIH All of Us Research Program.
Aug 18
•
Theral Timpson
4
1
47:28
Season Opener: Is Biology Having Its Newtonian Moment? with Rob Phillips, Caltech
Welcome to Mendelspod’s 16th season!
Aug 13
•
Theral Timpson
10
41:00
Season 16: Sponsorship Opportunities
Mendelspod is launching our 16th season tomorrow, continuing our conversations with the scientists, clinicians, entrepreneurs, and technology leaders…
Aug 12
•
Theral Timpson
16
From the Archives: Erdinc Sezgin and the Physics of Living Cells
On Mendelspod, we’re always searching for scientists who are looking at biology in new ways.
Aug 6
•
Theral Timpson
10
32:54
July 2026
From the Archives: How Cellanome Is Changing the Way We Study Cell Function with Matthew Spitzer and Pier Federico Gherardini
One of the biggest technology shifts we saw in biology over the past year came from the young company, Cellanome.
Jul 30
•
Theral Timpson
15
1
23:56
Agilent and Oxford Nanopore Discuss Bringing Long Reads to the Clinic with a Customer
Acute leukemia patients often wait days or even weeks for the full battery of molecular tests needed to guide treatment decisions.
Jul 9
•
Theral Timpson
1
1
29:01
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
